ACTIVE

BOFAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

2,1 M €

-20.0% YoY

Revenue

23,9 M €

+9.3% YoY

Equity

4,2 M €

+138.7% YoY

Workforce

6,3 ETP

-17.1% YoY

What does BOFAR do?

BOFAR is a Public limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wingene. It employs on average 6,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0425.935.908

Incorporation

20/06/1984

Legal form

Public limited company

Registered office

Flandria 3
8750 Wingene · FlandreSee on map

Contributed capital

76 000,00 €

Latest accounts

31/12/2025

Average workforce

6,3 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 46450Wholesale of perfume and cosmetics 46450Wholesale of perfume and cosmetics 51450Air transport

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Revenue	23,9 M €	+9.3%	21,9 M €		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–
EBITDA	2,7 M €	-26.7%	3,7 M €	+183%	1,3 M €	+6.9%	1,2 M €	-15.0%	1,4 M €	+13.7%	1,3 M €	+43.4%	885,2 k €	+72.0%	514,5 k €	+97.0%	261,2 k €	-25.0%	348,1 k €	+71.7%	202,8 k €	+3.3%	196,2 k €	+51.3%	129,7 k €	-40.8%	219,1 k €	+0.9%	217,2 k €	+12.1%	193,9 k €	+55.9%	124,4 k €	-31.8%	182,3 k €	-88.3%	1,6 M €
Operating result	2,6 M €	-19.0%	3,2 M €	+156%	1,2 M €	+6.5%	1,2 M €	-15.6%	1,4 M €	+17.6%	1,2 M €	+44.1%	810,4 k €	+90.4%	425,6 k €	+96.8%	216,2 k €	-37.0%	343,3 k €	+81.3%	189,4 k €	+1.4%	186,9 k €	+56.9%	119,1 k €	-41.0%	201,8 k €	-3.1%	208,4 k €	+13.3%	183,9 k €	+58.7%	115,9 k €	+5.8%	109,6 k €	-92.8%	1,5 M €
Net result	2,1 M €	-20.0%	2,6 M €	+162%	1 M €	+6.6%	938,2 k €	-8.8%	1 M €	+16.1%	886 k €	+38.7%	638,9 k €	+100%	319 k €	+84.0%	173,3 k €	-29.6%	246,3 k €	+95.7%	125,9 k €	+0.8%	124,9 k €	+61.8%	77,2 k €	-45.8%	142,4 k €	+0.8%	141,3 k €	+11.2%	127 k €	+167%	47,5 k €	-42.6%	82,7 k €	-92.0%	1 M €
Balance sheet
Equity	4,2 M €	+139%	1,8 M €	+53.8%	1,2 M €	-72.3%	4,2 M €	+29.2%	3,2 M €	+47.1%	2,2 M €	+68.3%	1,3 M €	+97.0%	658,8 k €	+93.9%	339,8 k €	+104%	166,5 k €	+137%	70,2 k €	+1.3%	69,3 k €	-0.1%	69,4 k €	-4.7%	72,8 k €	+1.9%	71,5 k €	+3.9%	68,8 k €	+0.1%	68,7 k €	+0.8%	68,2 k €	-7.6%	73,9 k €
Total assets	12,2 M €	+78.9%	6,8 M €	-15.6%	8 M €	-8.1%	8,7 M €	+0.5%	8,7 M €	+58.9%	5,5 M €	+32.7%	4,1 M €	+42.5%	2,9 M €	+36.0%	2,1 M €	+62.6%	1,3 M €	+62.8%	805 k €	+15.2%	698,6 k €	+0.5%	695,1 k €	-10.5%	776,6 k €	-16.2%	927,1 k €	+7.4%	862,9 k €	+14.5%	753,8 k €	+15.6%	652,1 k €	-84.2%	4,1 M €
Cash	661,2 k €	+91.7%	344,9 k €	-73.7%	1,3 M €	-31.0%	1,9 M €	-12.6%	2,2 M €	+12.5%	1,9 M €	+10.1%	1,8 M €	+176%	637 k €	+15.1%	553,5 k €	+87.9%	294,6 k €	+67.7%	175,7 k €	-25.2%	235 k €	+32.2%	177,7 k €	+14.7%	155 k €	+69.4%	91,5 k €	+12.5%	81,4 k €	-67.2%	248 k €	+19.7%	207,2 k €	-84.3%	1,3 M €
Debts	4,6 M €	-8.2%	5 M €	-27.2%	6,9 M €	+49.9%	4,6 M €	-16.3%	5,5 M €	+66.7%	3,3 M €	+16.4%	2,8 M €	+26.5%	2,2 M €	+25.1%	1,8 M €	+84.8%	969,2 k €	+31.9%	734,8 k €	+16.8%	629,3 k €	+0.8%	624,1 k €	-11.1%	702,4 k €	-17.8%	854,4 k €	+8.0%	791,4 k €	+15.5%	685,1 k €	+17.3%	583,9 k €	-85.6%	4 M €
Other
Workforce	6,3 ETP	-17.1%	7,6 ETP	0.0%	7,6 ETP	-11.6%	8,6 ETP	+26.5%	6,8 ETP	+1.5%	6,7 ETP	+48.9%	4,5 ETP	+4.7%	4,3 ETP	+22.9%	3,5 ETP	+66.7%	2,1 ETP	+16.7%	1,8 ETP	+63.6%	1,1 ETP	+10.0%	1,0 ETP	-16.7%	1,2 ETP	+20.0%	1,0 ETP	0.0%	1,0 ETP	+42.9%	0,7 ETP	-72.0%	2,5 ETP	0.0%	2,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 18 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 14 août 2025 · until 14 août 2031 · 0799.344.237

Represented by Benoit Devroe

Active

Bobbie Company

Managing director · since 16 mars 2023 · until 14 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active

Cecile Hoogmartens

Director · since 16 mars 2023 · until 16 mars 2029

Active

CéVéGé

Director · since 16 mars 2023 · until 16 mars 2029 · 0888.599.974

Represented by Chris Verstraete

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended

Bobbie Company

Director · since 16 mars 2023 · until 16 mars 2029 · 0685.530.177

Represented by Benoit DEVROE

Ended

Bobbie Company

Director · since 16 mars 2023 · until 31 décembre 2029 · 0685.530.177

Represented by Benoit DEVROE

Ended

Cecile Hoogmartens

Director · since 16 mars 2023 · until 31 décembre 2029

Ended

At this address

Other companies at this address

Company	CBE no.
Bobbie Pharmaceutical Services● Active	0799.344.237
VERGEL● Active	0812.259.489
VERGEL GROUP● Active	1026.206.055

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	10/07/2025	30/08/2024	07/10/2023	28/08/2022	31/08/2021
General meeting	30/06/2026	27/06/2025	29/08/2024	06/06/2023	07/06/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	20/07/2026	Dutch	PDF
Full model	31/12/2024	27/06/2025	10/07/2025	Dutch	PDF
Abridged model	31/12/2023	29/08/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	06/06/2023	07/10/2023	Dutch	PDF
Abridged model	31/12/2021	07/06/2022	28/08/2022	Dutch	PDF
Abridged model	31/12/2020	28/05/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	21/08/2020	11/11/2020	Dutch	PDF
Abridged model	31/12/2018	04/06/2019	27/09/2019	Dutch	PDF
Abridged model	31/12/2017	05/06/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	06/06/2017	28/08/2017	Dutch	PDF
Abridged model	31/12/2015	26/05/2016	26/08/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	28/08/2015	Dutch	PDF
Abridged model	31/12/2013	22/09/2014	25/09/2014	Dutch	PDF
Abridged model	31/12/2012	30/08/2013	08/10/2013	Dutch	PDF
Abridged modelCorrection	31/12/2011	04/09/2012	08/10/2012	Dutch	PDF
Abridged model	31/12/2011	04/09/2012	06/09/2012	Dutch	PDF
Abridged model	31/12/2010	28/06/2011	29/06/2011	Dutch	PDF
Abridged model	31/12/2009	01/06/2010	22/06/2010	Dutch	PDF
Abridged model	31/12/2008	02/06/2009	22/07/2009	Dutch	PDF
Abridged model	31/12/2007	03/06/2008	26/06/2008	Dutch	PDF
Abridged model	31/12/2006	05/06/2007	23/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 18 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 14 août 2025 · until 14 août 2031 · 0799.344.237

Represented by Benoit Devroe

Active

Bobbie Company

Managing director · since 16 mars 2023 · until 14 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active

Cecile Hoogmartens

Director · since 16 mars 2023 · until 16 mars 2029

Active

CéVéGé

Director · since 16 mars 2023 · until 16 mars 2029 · 0888.599.974

Represented by Chris Verstraete

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended

Bobbie Company

Director · since 16 mars 2023 · until 16 mars 2029 · 0685.530.177

Represented by Benoit DEVROE

Ended

Bobbie Company

Director · since 16 mars 2023 · until 31 décembre 2029 · 0685.530.177

Represented by Benoit DEVROE

Ended

Cecile Hoogmartens

Director · since 16 mars 2023 · until 31 décembre 2029

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring12/02/2026
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring24/11/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates10/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/04/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Registered office04/04/2018
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20252,1 M €↓
2024
Annual accounts 20242,6 M €↑
2023
Annual accounts 20231 M €↑
2022
Annual accounts 2022938,2 k €↓
2021
Annual accounts 20211 M €↑
2020
Annual accounts 2020886 k €↑
2019
Annual accounts 2019638,9 k €↑
2018
Annual accounts 2018319 k €↑
2017
Annual accounts 2017173,3 k €↓
2016
Annual accounts 2016246,3 k €↑
2015
Annual accounts 2015125,9 k €↑
2014
Annual accounts 2014124,9 k €↑
2013
Annual accounts 201377,2 k €↓
2012
Annual accounts 2012142,4 k €↑
2011
Annual accounts 2011141,3 k €↑
2010
Annual accounts 2010127 k €↑
2009
Annual accounts 200947,5 k €↓
2008
Annual accounts 200882,7 k €↓
2007
Annual accounts 20071 M €
20/06/1984
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BOFAR

Overview

What does BOFAR do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline